| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $19K | +261.2% |
| Cost of Revenue | $6K | +117.5% |
| Gross Profit | $13K | +431.8% |
| R&D Expense | $2.9M | +17.0% |
| SG&A Expense | $3.4M | -5.9% |
| Operating Income | -$6.3M | -3.2% |
| Interest Expense | $354K | +45.6% |
| Net Income | -$6.6M | -3.9% |
| EPS (Basic) | -$19.00 |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | +249.8% |
| Inventory | $629K | -7.0% |
| Current Assets | $7.4M | +172.7% |
| Total Assets | $9.5M | +189.1% |
| Current Liabilities | $1.8M | -4.4% |
| Total Liabilities | $2.2M | -28.5% |
| Stockholders' Equity | $7.3M | +3073.7% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | -5.1% |
| Capital Expenditures | $64K | +252.1% |
| Investing Cash Flow | -$125K | -584.2% |
| Financing Cash Flow | $10.3M | +58.3% |
| Free Cash Flow | -$6.1M | -5.9% |
| -2275.0% |
| EPS (Diluted) | -$19.00 | -2275.0% |